UPPSALA, Sweden — MAGic BioProcessing is pleased to announce the appointment of Günter Jagschies new board member while also acknowledging the departure of our valued board member Kristina Köhler. These changes mark an important step in the company’s ongoing commitment to excellence and strategic growth. Dr. Jagschies brings a wealth of experience and expertise in the bioprocessing […]
MILFORD, Mass. — Waters Corporation (NYSE:WAT) today announced the appointment of Heather Knight to its Board of Directors effective August 14, 2024. Ms. Knight currently serves as Executive Vice President and Group President, Medical Products and Therapies at Baxter International. Heather is an accomplished leader who brings decades of experience across the pharma and medical device […]
REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced it has appointed Dr. Nicolas Roelofs to serve on its Board of Directors. “Nick is a fantastic addition to our board, bringing over 35 years of broad operational and advisory experience with leading […]
FREMONT, Calif. — Ultima Genomics, a developer of an innovative new ultra-high throughput sequencing architecture, today announced the addition of two industry leaders focused on driving operational excellence and commercial adoption. The appointments follow the strong uptake of Ultima’s technology in clinical applications and will accelerate the Company’s path towards expanded clinical utilization as well […]
BiotageAB (STO:BIOT) (“Biotage”), the leading global separations Company developing intelligent workflow solutions for drug discovery and development through to diagnostics, has today announced the appointment of Frederic Vanderhaegen as Chief Executive Officer, effective September 16th 2024. Mr. Vanderhaegen succeeds Torben Jørgensen, who stepped in as interim CEO in January 2024 and he will now continue […]
LEBANON, N.H. — Bio X Cell, LLC (“BXC” or the “Company”), a leading producer of monoclonal antibodies for pre-clinical in vivo research applications, is pleased to announce the appointment of Christopher Conway as Chief Executive Officer. Bio X Cell is a leading producer of monoclonal antibodies (mAbs) primarily for use in preclinical in vivo research […]
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Michael Feld has been named executive vice president and president of the Life Sciences segment for BD, effective Aug. 20, 2024, and will serve as a member of the Executive Leadership Team. He succeeds Dave Hickey, who retired from BD […]
TAIPEI, Taiwan & WATERTOWN, Mass. — Syncell, a leader in next-generation spatial proteomics, is pleased to announce the addition of Philippe C. Lyko as Chief Financial Officer (CFO) and Nikhil Rao, PhD, as Senior Vice President of Commercial. These appointments strengthen Syncell’s leadership team as the company enters a pivotal phase of growth and commercial […]
Berwyn, Pa. – AMETEK, Inc. (NYSE: AME) today announced the appointment of John C. Henriques as Vice President, Corporate Development. “I am very pleased to announce John’s promotion to this important role, as he has been a valuable contributor to our Corporate Development team,” commented David A. Zapico, AMETEK Chairman and Chief Executive Officer. “His […]
Berwyn, Pa. – AMETEK, Inc. (NYSE: AME) today announced the appointment of Rob Rideout Jr. as Vice President, Strategic Procurement. “I am delighted to promote Rob to Vice President, Strategic Procurement,” said David A. Zapico, AMETEK Chairman and Chief Executive Officer. “Rob’s exceptional leadership and expertise in supply chain management have been invaluable. We are […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
